Literature DB >> 9814647

Transfusion-transmitted Chagas' disease.

S Wendel.   

Abstract

Transfusion-transmitted Chagas' disease has been recognized since 1952. Until recently, no cases were reported outside of Latin America. However, emigration during the past 20 years expanded its transfusional geographic borders to North America. Trypanosoma cruzi-infected donors usually are asymptomatic, often for a lifetime. This situation complicates donor screening, particularly in regions where blood bank personnel are not familiar with the risk factors and natural history of this transfusion-transmitted infection. This review addresses the main aspects of epidemiology, risks of infection, clinical symptoms in donors and recipients, preventive measures, and blood donor screening to prevent transfusion-transmitted Chagas' disease.

Entities:  

Mesh:

Year:  1998        PMID: 9814647     DOI: 10.1097/00062752-199811000-00009

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  9 in total

1.  Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits.

Authors:  D A Leiby; S Wendel; D T Takaoka; R M Fachini; L C Oliveira; M A Tibbals
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.

Authors:  Christoph Niederhauser; Jochen Gottschalk; Caroline Tinguely
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

4.  In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters.

Authors:  Mohamed A Jamal; Ray Y Hachem; Joel Rosenblatt; Mark J McArthur; Edd Felix; Ying Jiang; Ramesh C Tailor; Issam Raad
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.

Authors:  Vladimir Michailowsky; Keith Luhrs; Manoel Otávio C Rocha; David Fouts; Ricardo T Gazzinelli; Jerry E Manning
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

Review 6.  Epidemiology of Chagas disease in Europe: many calculations, little knowledge.

Authors:  Jörn Strasen; Tatjana Williams; Georg Ertl; Thomas Zoller; August Stich; Oliver Ritter
Journal:  Clin Res Cardiol       Date:  2013-08-29       Impact factor: 5.460

7.  Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

Authors:  Zuleima C Caballero; Octavio E Sousa; Waldelania P Marques; Amadeo Saez-Alquezar; Eufrosina S Umezawa
Journal:  Clin Vaccine Immunol       Date:  2007-05-23

Review 8.  Emerging infectious diseases that threaten the blood supply.

Authors:  Harvey J Alter; Susan L Stramer; Roger Y Dodd
Journal:  Semin Hematol       Date:  2007-01       Impact factor: 3.851

9.  Prevention strategies of transfusion-transmitted parasitic infections (TTPIs): Strengths and challenges of current approaches, and evaluation of the strategies implemented in Iran.

Authors:  Ahmad Mardani
Journal:  Parasite Epidemiol Control       Date:  2020-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.